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Background
Both Foradil Aerolizer (formoterol fumarate
inhalation powder), a long-acting, selective beta-2
adrenergic agonist, and Spiriva HandiHaler
(tiotropium bromide inhalation powder), a longacting anticholinergic bronchodilator, are supplied
as powder in a capsule-loaded dosage form.1 In
Canada, Intal Spincaps (sodium cromoglycate), a
mast cell stabilizer, is also supplied in a capsular
form.2 These capsules are intended only for
loading into the brand name dry-inhalation device.
Because these capsules look like capsules for oral
administration, accidental oral administration can
occur.

Commentary
The FDA has received reports of
misadministration of these capsules. Thirty cases
of oral administration of Foradil inhalation
capsules and two cases of oral administration of
Spiriva inhalation capsules have been reported.3
Though very few of these reports indicated
adverse outcomes, inappropriate administration
obviously results in decreased therapeutic
outcomes.
One case reported difficulty in
breathing and in another case the patient required
hospitalization due to exacerbation of chronic
obstructive
pulmonary
disease.
Oral
administration of these capsules resulted because
the packaging and labeling did not readily display
“not for oral use” warnings.
Manufacturers are currently revising package
and product labels to assure safe and appropriate
administration. It is not known when these
products with revised labeling will reach
pharmacies.
Whenever the inhalation capsules are separated
from the inhalation device, the potential for oral

administration is increased.
Healthcare
professionals should affix supplemental warning
labels to capsules whenever the inhalation
capsules are separated from devices. Patients
should be counseled to store the capsules with the
inhalers to avoid confusion and they should be
shown how to correctly load the capsules and use
the inhaler.
Report any cases of misadministration. In the
US, call the FDA MEDWATCH program at 1800-FDA-1088. The MEDWATCH program is
also available on-line at www.fda.gov/medwatch.
Or report to the USP Medication Errors Reporting
Program in cooperation with the Institute for Safe
Medication Practices at 1-800-23-ERROR or at
www.usp.org/patientSafety/reporting/mer.html.
In Canada, call the Canadian Adverse Drug
Reaction Monitoring Program at 1-866-234-2345.
The Canadian adverse reaction reporting form can
be found at: http://www.hc-sc.gc.ca/hpfbdgpsa/tpd-dpt/adverse_e.pdf.
It should be
completed and faxed to 1-866-678-6789. You can
also contact the Institute for Safe Medication
Practices (ISMP) by calling 215-947-7797 or
reporting on-line at www.ismp.org/Pages/
communications.asp.

Sound-Alike, Look-Alike Concern
Recently, a sound-alike, look-alike SpirivaInspra concern was reported to the Institute for
In the
Safe Medication Practices (ISMP).4
reported case, Spiriva 25 mg orally daily was
ordered. A pharmacist intercepted the order due
to the oral route of administration and clarified the
order to Inspra 25 mg orally daily.
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Users of this document are cautioned to use their own
professional judgment and consult any other necessary
or appropriate sources prior to making clinical
judgments based on the content of this document. Our
editors have researched the information with input
from experts, government agencies, and national
organizations. Information and Internet links in this
article were current as of the date of publication.
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